Fibrinogen-like protein 2 expression correlates with microthrombosis in rats with type 2 diabetic nephropathy

Ritz, 1999, Nephropathy in patients with type 2 diabetes mellitus, N Engl J Med, 341, 1127, 10.1056/NEJM199910073411506 Cooper, 1998, Pathogenesis, prevention, and treatment of diabetic nephropathy, Lancet, 352, 213, 10.1016/S0140-6736(98)01346-4 Kanková, 2008, Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?, Proc Nutr Soc, 67, 60, 10.1017/S0029665108006034 Schena, 2005, Pathogenetic mechanisms of diabetic nephropathy, J Am Soc Nephrol, 16, S30-, 10.1681/ASN.2004110970 Vallon, 1999, Glomerular hyperfiltration in experimental diabetes mellitus, J Am Soc Nephrol, 10, 2569, 10.1681/ASN.V10122569 Ghanekar, 2004, Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection, J Immunol, 172, 5693, 10.4049/jimmunol.172.9.5693 Boeri, 2001, Increased prevalence of microthrombosis in retinal capillaries of diabetic individuals, Diabetes, 50, 1432, 10.2337/diabetes.50.6.1432 Levy, 2000, Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis, Am J Pathology, 156, 1217, 10.1016/S0002-9440(10)64992-9 Chan, 2002, Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity, J Immunol, 168, 5170, 10.4049/jimmunol.168.10.5170 Marsden, 2003, The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis, J Clin Invest, 112, 58, 10.1172/JCI18114 Mendicino, 2005, Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts, Circulation, 112, 248, 10.1161/CIRCULATIONAHA.105.534271 Clark, 2004, The fgl2 prothrombinase/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction, Mol Hum Reprod, 10, 99, 10.1093/molehr/gah013 Knackstedt, 2003, Th1 cytokines and the prothrombinase fgl2 in stress-triggered and inflammatory abortion, Am J Reprod Immunol, 49, 210, 10.1034/j.1600-0897.2003.01192.x Luo, 1998, Nongenetic mouse models of non-insulin-dependent diabetes mellitus, Metabolism, 47, 663, 10.1016/S0026-0495(98)90027-0 Doolittle, 1983, The structure and evolution of vertebrate fibrinogen, Ann N Y Acad Sci, 408, 13, 10.1111/j.1749-6632.1983.tb23231.x Boden, 2007, Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose, J Clin Endocrinol Metab, 92, 4352, 10.1210/jc.2007-0933 Bruno, 2005, Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study, Diabetologia, 48, 427, 10.1007/s00125-004-1667-1 Su, 2008, Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma, World J Gastroenterol, 14, 5980, 10.3748/wjg.14.5980 Liu, 2006, Identification of the receptor for FGL2 and implications for susceptibility to mouse hepatitis virus (MHV-3)-induced fulminant hepatitis, Adv Exp Med Biol, 581, 421, 10.1007/978-0-387-33012-9_76 Guest, 2008, The implication of proinflammatory cytokines in type 2 diabetes, Front Biosci, 13, 5187, 10.2741/3074 Fornoni, 2008, Role of inflammation in diabetic nephropathy, Curr Diabetes Rev, 4, 10, 10.2174/157339908783502361 Dhalla, 1998, Subcellular remodeling and heart dysfunction in chronic diabetes, Cardiovasc Res, 40, 239, 10.1016/S0008-6363(98)00186-2 Moller, 2000, Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes, Trends Endocrinol Metab, 11, 212, 10.1016/S1043-2760(00)00272-1 Peraldi, 1998, TNF-alpha and insulin resistance: summary and future prospects, Mol Cell Biochem, 182, 169, 10.1023/A:1006865715292 Liu, 2006, Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements, J Immunol, 176, 7028, 10.4049/jimmunol.176.11.7028 Hancock, 2004, Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2, Proc Natl Acad Sci USA, 101, 3005, 10.1073/pnas.0308369101 Ning, 2005, Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection, J Immunol, 174, 7403, 10.4049/jimmunol.174.11.7403 Hamada, 1996, Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway, Biochem Biophys Res Commun, 228, 539, 10.1006/bbrc.1996.1695 Forbes, 2008, Oxidative stress as a major culprit in kidney disease in diabetes, Diabetes, 57, 1446, 10.2337/db08-0057 Evans, 2002, Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes, Endocr Rev, 23, 599, 10.1210/er.2001-0039 Noh, 2007, The role of protein kinase C activation in diabetic nephropathy, Kidney Int, 72, S49, 10.1038/sj.ki.5002386 Wolf, 2004, New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology, Eur J Clin Invest, 34, 785, 10.1111/j.1365-2362.2004.01429.x Remuzzi, 2006, Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes, J Clin Invest, 116, 288, 10.1172/JCI27699